XML 17 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Cash flows from operating activities:    
Net loss $ (1,034,681) $ (1,184,497)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 9,016 8,160
Bad debt expense 6,646 758
Amortization of deferred financing costs 59,761 2,124
Amortization of beneficial conversion option 188,385
Stock issued for services 57,500 62,500
Stock options compensation 91,063 113,589
Note conversion warrant expense 137,970
Note offer warrant expense 54,015
Changes in operating assets and liabilities:    
Accounts receivable (204,219) (112,814)
Prepaid expenses and other current assets (14,338) (125,544)
Accounts payable and accrued expenses 63,275 (116,262)
Other long-term liabilities - related parties 24,806 (12,852)
Deferred interest expense (3,230) 23,226
Deferred revenues (103,403) (46,007)
Total adjustments 229,277 (65,152)
Net cash used in operating activities (805,404) (1,249,649)
Cash flows from investing activities:    
Purchases of property and equipment (14,202) (6,867)
Net cash used in investing activities (14,202) (6,867)
Cash flows from financing activities:    
Sale of Common Stock 559,285
Exercise of stock options 3,500
Payment of deferred financing costs (103,328)
Proceeds from notes payable 560,000
Proceeds from notes payable - related parties 150,000
Repayment of notes payable (268,195) (180,000)
Repayment of notes payable - related parties (25,114) (83,834)
Net cash provided by financing activities 313,363 298,951
Net increase (decrease) in cash (506,243) (957,565)
Cash - beginning of period 689,946 1,117,118
Cash - end of period 183,703 159,553
Supplemental disclosure of cash flow information:    
Cash paid during the period for interest and taxes 89,071 35,808
Supplemental disclosure of non-cash financing activities:    
Accrued interest notes payable converted to equity 35,038
Discount on notes payable for beneficial conversion feature 248,523
Discount on notes payable - related parties for warrants 38,836
Notes payable conversion warrant expense 113,762
Notes payable conversion underwriting warrant expense 24,207
Notes payable converted to equity $ 135,000